Novo Nordisk Gains, Maersk Slumps, BMW's EV Upside

On this episode of Stock Movers:

- Novo Nordisk shares gained on expectations that competition for its blockbuster obesity shot Wegovy will subside later this year.

- BMW’s earnings declined less than expected in the first quarter as electric vehicle sales in Europe helped buoy the German carmaker amid slumping demand in China and the threat of US tariffs.

- Maersk and other European sea-freight stocks decline on the prospect of lower shipping rates after President Donald Trump said the US would stop its bombing campaign against Houthis in Yemen.

See omnystudio.com/listener for privacy information.